These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 2639729)

  • 1. Effects of tiazofurin on globin and proto-oncogene expression in K562 erythroleukemia cells.
    Kharbanda SM; Miyazaki K; Takeyama H; Sherman ML; Spriggs DR; Carney WP; Kufe DW
    Cancer Commun; 1989; 1(3):191-7. PubMed ID: 2639729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of tiazofurin on protooncogene expression during HL-60 cell differentiation.
    Kharbanda SM; Sherman ML; Spriggs DR; Kufe DW
    Cancer Res; 1988 Nov; 48(21):5965-8. PubMed ID: 2901907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of c-myc and c-Ha-ras gene expression by tiazofurin in rat hepatoma cells.
    Olah E; Kote Z; Natsumeda Y; Yamaji Y; Jarai G; Lapis E; Financsek I; Weber G
    Cancer Biochem Biophys; 1990 Apr; 11(2):107-17. PubMed ID: 1974479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tiazofurin induction of mouse erythroleukemia cell hemoglobin production in the absence of commitment or changes in protooncogene expression.
    Sherman ML; Shafman TD; Colman MS; Kufe DW
    Blood; 1989 Feb; 73(2):431-4. PubMed ID: 2917182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of erythroid differentiation in K562 cells by inhibitors of inosine monophosphate dehydrogenase.
    Yu J; Lemas V; Page T; Connor JD; Yu AL
    Cancer Res; 1989 Oct; 49(20):5555-60. PubMed ID: 2571408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in gene expression during hexamethylene bisacetamide induced erythroleukemia differentiation.
    Marks PA; Ramsay R; Sheffery M; Rifkind RA
    Prog Clin Biol Res; 1987; 251():253-68. PubMed ID: 3481077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms in the antiproliferative action of taxol and tiazofurin.
    Olah E; Csokay B; Prajda N; Kote-Jarai Z; Yeh YA; Weber G
    Anticancer Res; 1996; 16(5A):2469-77. PubMed ID: 8917337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coordinate change of c-myc, transferrin receptor and H3 gene expression precedes induction of haemoglobin-producing cells of the leukaemia K562 cell line treated with cis-diamminedichloroplatinum (II).
    Marazzi L; Parodi MT; Di Martino D; Ferrari S; Tonini GP
    Anticancer Res; 1991; 11(2):947-52. PubMed ID: 2064352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tiazofurin decreases Ras-GTP complex in K562 cells.
    Hata Y; Natsumeda Y; Weber G
    Oncol Res; 1993; 5(4-5):161-4. PubMed ID: 8305741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protooncogene expression in normal, preleukemic, and leukemic murine erythroid cells and its relationship to differentiation and proliferation.
    Robert-Lézénès J; Meneceur P; Ray D; Moreau-Gachelin F
    Cancer Res; 1988 Jul; 48(14):3972-6. PubMed ID: 3164254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. cAMP differentially regulates gamma-globin gene expression in erythroleukemic cells and primary erythroblasts through c-Myb expression.
    Kuroyanagi Y; Kaneko Y; Muta K; Park BS; Moi P; Ausenda S; Cappellini MD; Ikuta T
    Biochem Biophys Res Commun; 2006 Jun; 344(3):1038-47. PubMed ID: 16631597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IMP dehydrogenase inhibitor, tiazofurin, induces apoptosis in K562 human erythroleukemia cells.
    Vitale M; Zamai L; Falcieri E; Zauli G; Gobbi P; Santi S; Cinti C; Weber G
    Cytometry; 1997 Feb; 30(1):61-6. PubMed ID: 9056744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of 1-beta-D-arabinofuranosylcytosine on proto-oncogene expression in human U-937 cells.
    Mitchell T; Sariban E; Kufe D
    Mol Pharmacol; 1986 Oct; 30(4):398-402. PubMed ID: 3531806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationships between the cytotoxicity of tiazofurin and its metabolism by cultured human lung cancer cells.
    Carney DN; Ahluwalia GS; Jayaram HN; Cooney DA; Johns DG
    J Clin Invest; 1985 Jan; 75(1):175-82. PubMed ID: 2856924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the IMP-dehydrogenase inhibitor, Tiazofurin, in bcr-abl positive acute myelogenous leukemia. Part II. In vitro studies.
    Wright DG; Boosalis M; Malek K; Waraska K
    Leuk Res; 2004 Nov; 28(11):1137-43. PubMed ID: 15380336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythroid differentiation and modulation of c-myc expression induced by antineoplastic drugs in the human leukemic cell line K562.
    Tonini GP; Radzioch D; Gronberg A; Clayton M; Blasi E; Benetton G; Varesio L
    Cancer Res; 1987 Sep; 47(17):4544-7. PubMed ID: 3476195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the antisense myb expression on hemin- and erythropoietin-induced erythroid differentiation of K562 cells.
    Kamano H; Tanaka T; Ohnishi H; Kubota Y; Ikeda K; Takahara J; Irino S; Ottalenghi S
    Biochem Mol Biol Int; 1994 Aug; 34(1):85-92. PubMed ID: 7849628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Action of 2-beta-d-Ribofuranosylthiazole-4-carboxamide (tiazofurin) in Chinese hamster ovary and variant cell lines.
    Saunders PP; Kuttan R; Lai MM; Robins RK
    Mol Pharmacol; 1983 Mar; 23(2):534-9. PubMed ID: 6188036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of 1-beta-D-arabinofuranosylcytosine and phorbol ester on differentiation of human K562 erythroleukemia cells.
    Watanabe T; Mitchell T; Sariban E; Sabbath K; Griffin J; Kufe D
    Mol Pharmacol; 1985 Jun; 27(6):683-8. PubMed ID: 3858662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Myb dependent pathway maintains Friend murine erythroleukemia cells in an immature and proliferating state.
    Chen J; Kremer CS; Bender TP
    Oncogene; 2002 Mar; 21(12):1859-69. PubMed ID: 11896618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.